B Desoize|J Jardillier - JoVE Visualize

Showing results (51-60 of 54) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 54 results.

Anticancer Research|March 1, 1996

Prognostic significance of routine clinical and laboratory data in advanced head and neck cancersC Himberlin, J C Merol, S Nasca, et al.

Biochemical Pharmacology|October 19, 1993

The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and IIA K Larsen, L Grondard, J Couprie, et al.

Anticancer Research|July 1, 1991

Combination chemotherapy with cisplatin, etoposide and gallium chloride for lung cancer: individual adaptation of dosesP Collery, M Morel, B Desoize, et al.

Physical Review Letters|September 28, 2004

Measurement of the generalized polarizabilities of the proton in virtual Compton scattering at Q2=0.92 and 1.76 GeV2G Laveissière, L Todor, N Degrande, et al.

Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 54 results.

Anticancer Research|March 1, 1996

Prognostic significance of routine clinical and laboratory data in advanced head and neck cancersC Himberlin, J C Merol, S Nasca, et al.

Biochemical Pharmacology|October 19, 1993

The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and IIA K Larsen, L Grondard, J Couprie, et al.

Anticancer Research|July 1, 1991

Combination chemotherapy with cisplatin, etoposide and gallium chloride for lung cancer: individual adaptation of dosesP Collery, M Morel, B Desoize, et al.

Physical Review Letters|September 28, 2004

Measurement of the generalized polarizabilities of the proton in virtual Compton scattering at Q2=0.92 and 1.76 GeV2G Laveissière, L Todor, N Degrande, et al.

Pageof 6